Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Thomas F. Gajewski

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Gajewski, Thomas F.

Item TypeName
Concept Oncogenes
Concept Proto-Oncogene Proteins
Concept Oncogene Proteins, Viral
Concept Proto-Oncogene Proteins c-bcl-2
Concept Proto-Oncogene Proteins B-raf
Concept Proto-Oncogene Proteins c-kit
Concept Proto-Oncogene Proteins c-cbl
Concept Proto-Oncogene Proteins p21(ras)
Concept Proto-Oncogene Proteins c-fyn
Concept Proto-Oncogenes
Concept Proto-Oncogene Proteins c-akt
Academic Article Apoptosis meets signal transduction: elimination of a BAD influence.
Academic Article Blocked Ras activation in anergic CD4+ T cells.
Academic Article Interleukin-12-secreting human papillomavirus type 16-transformed cells provide a potent cancer vaccine that generates E7-directed immunity.
Academic Article Death of peripheral CD8+ T cells in the absence of MHC class I is Fas-dependent and not blocked by Bcl-xL.
Academic Article Molecular profiling of melanoma and the evolution of patient-specific therapy.
Academic Article Evidence implicating the Ras pathway in multiple CD28 costimulatory functions in CD4+ T cells.
Academic Article Induction of the increased Fyn kinase activity in anergic T helper type 1 clones requires calcium and protein synthesis and is sensitive to cyclosporin A.
Academic Article Differential requirement for protein tyrosine kinase Fyn in the functional activation of antigen-specific T lymphocyte clones through the TCR or Thy-1.
Academic Article An adenoviral vector encoding dominant negative Cbl lowers the threshold for T cell activation in post-thymic T cells.
Academic Article CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells.
Academic Article Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104).
Academic Article Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.
Academic Article Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study.
Academic Article Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma.
Academic Article Conditional deletion of PTEN in peripheral T cells augments TCR-mediated activation but does not abrogate CD28 dependency or prevent anergy induction.
Academic Article Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition.
Academic Article Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.
Academic Article Tumor-intrinsic oncogene pathways mediating immune avoidance.
Academic Article Impact of oncogenic pathways on evasion of antitumour immune responses.
Academic Article Extended 5-Year Follow-up Results of a Phase Ib Study (BRIM7) of Vemurafenib and Cobimetinib in BRAF-Mutant Melanoma.

Search Criteria
  • Oncogenes